P147: A phenotypic NS3‐protease inhibitor resistance assay to characterize resistance‐associated mutations in patients

E-ISSN： 1365-2893|22|S2|93-93

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 93-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma

By Hong Xuan Yang Zhao-Yang Wang Meng Lu Lu Li Ying-Hong Hao Xishan Chen Gong-Yan

International Journal of Molecular Medicine, Vol. 28, Iss. 6, 2011-12 ,pp. : 953-960

Spandidos Publications

Access to resources Recommend Favorite

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E115-E121

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea

By Lee S. B.

Annals of Tropical Medicine and Parasitology, Vol. 95, Iss. 4, 2001-06 ,pp. : 429-432

Routledge Ltd

Access to resources Recommend Favorite

Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 159-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with FLT3 inhibitor in patients with FLT3‐mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2142-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite